Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Short Interest Down 72.4% in May

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) saw a large decrease in short interest during the month of May. As of May 15th, there was short interest totaling 19,453 shares, a decrease of 72.4% from the April 30th total of 70,535 shares. Based on an average trading volume of 159,209 shares, the short-interest ratio is presently 0.1 days. Currently, 0.0% of the company’s stock are sold short.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on XTNT. Craig Hallum restated a “buy” rating on shares of Xtant Medical in a report on Wednesday, March 18th. BTIG Research restated a “buy” rating and issued a $1.00 target price on shares of Xtant Medical in a report on Wednesday, May 13th. Two investment analysts have rated the stock with a Buy rating, According to MarketBeat, Xtant Medical presently has a consensus rating of “Buy” and a consensus price target of $1.00.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of XTNT. Jane Street Group LLC bought a new position in shares of Xtant Medical during the 2nd quarter valued at approximately $26,000. Tradition Wealth Management LLC bought a new position in shares of Xtant Medical during the 4th quarter valued at approximately $79,000. Wiregrass Investment Management LLC bought a new position in shares of Xtant Medical during the 4th quarter valued at approximately $81,000. Mink Brook Asset Management LLC grew its position in shares of Xtant Medical by 125.8% during the 2nd quarter. Mink Brook Asset Management LLC now owns 109,466 shares of the medical device company’s stock valued at $81,000 after acquiring an additional 60,997 shares during the period. Finally, Nano Cap New Millennium Growth Fund L P bought a new position in shares of Xtant Medical during the 4th quarter valued at approximately $220,000. 69.33% of the stock is owned by institutional investors.

Xtant Medical Stock Down 1.7%

NYSEAMERICAN:XTNT traded down $0.01 on Friday, hitting $0.46. The stock had a trading volume of 109,741 shares, compared to its average volume of 159,587. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.64 and a current ratio of 3.34. The stock has a market cap of $64.80 million, a P/E ratio of 46.25 and a beta of -0.16. Xtant Medical has a 1 year low of $0.44 and a 1 year high of $0.95. The firm’s fifty day simple moving average is $0.51 and its two-hundred day simple moving average is $0.60.

Xtant Medical (NYSEAMERICAN:XTNT) last posted its quarterly earnings data on Wednesday, May 13th. The medical device company reported ($0.02) EPS for the quarter, meeting the consensus estimate of ($0.02). The firm had revenue of $20.88 million during the quarter, compared to analyst estimates of $20.16 million. Xtant Medical had a net margin of 1.50% and a return on equity of 3.68%.

About Xtant Medical

Xtant Medical, Inc is a medical technology company focused on the development, manufacturing and distribution of bone graft, spine biologics and related implantable medical devices. The company’s product portfolio is designed to address critical needs in spinal fusion, orthopedics and trauma surgery by providing a range of solutions that promote bone growth, structural support and patient recovery.

The company’s offerings include an array of bone graft substitutes – such as demineralized bone matrix putties and fibers – interbody fusion devices, spinal fixation systems and biologic agents.